Ignite Creation Date:
2024-05-06 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04681729
Status:
COMPLETED
Last Update Posted:
2024-02-21
First Post:
2020-12-18
Brief Title:
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine LIBERTY-CINDU CUrIADS
Sponsor:
Organization:
Sanofi